Aquestive Therapeutics, Inc. Increase (Decrease) in Inventories
Aquestive Therapeutics, Inc. (AQST) reported Increase (Decrease) in Inventories of $1.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-11
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$706.00K, a 176.16% decline year-over-year.
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.90M, a 64.30% increase year-over-year.
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$1.71M.
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$241.00K, a 538.18% decline year-over-year.
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for fiscal 2025 was $126.00K.
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for fiscal 2024 was -$725.00K, a 173.31% decline from fiscal 2023.
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for fiscal 2023 was $989.00K, a 43.26% decline from fiscal 2022.
- Aquestive Therapeutics, Inc. increase (decrease) in inventories for fiscal 2022 was $1.74M, a 10.53% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$706.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.19M 10-Q · filed 2026-08-11 | -$524.00K derived: sum of 3 quarters · filed 2026-08-11 | -$765.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-13 | $182.00K derived: sum of 2 quarters · filed 2026-05-13 | -$59.00K derived: sum of 3 quarters · filed 2026-05-13 | $868.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.96M derived: sum of 2 quarters · filed 2026-03-04 | -$1.03M derived: sum of 3 quarters · filed 2026-08-11 | $126.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | -$241.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $686.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.84M 10-Q · filed 2025-11-05 | $863.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $927.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $2.08M 10-Q · filed 2026-08-11 | $1.10M derived: sum of 3 quarters · filed 2026-08-11 | $1.16M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $1.15M 10-Q · filed 2026-05-13 | $177.00K derived: sum of 2 quarters · filed 2026-05-13 | $232.00K derived: sum of 3 quarters · filed 2026-05-13 | -$536.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$977.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$922.00K derived: sum of 2 quarters · filed 2026-03-04 | -$1.69M derived: sum of 3 quarters · filed 2026-03-04 | -$725.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$713.00K derived: sum of 2 quarters · filed 2025-11-05 | $252.00K 10-Q · filed 2025-11-05 | -$58.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $197.00K 10-Q · filed 2025-08-11 | -$113.00K derived: sum of 3 quarters · filed 2025-08-11 | $1.02M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $965.00K 10-Q · filed 2025-05-12 | $655.00K derived: sum of 2 quarters · filed 2025-05-12 | $1.78M derived: sum of 3 quarters · filed 2025-05-12 | $753.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $819.00K derived: sum of 2 quarters · filed 2025-03-05 | -$212.00K derived: sum of 3 quarters · filed 2025-03-05 | $989.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $98.00K derived: sum of 2 quarters · filed 2024-11-04 | $1.30M 10-Q · filed 2024-11-04 | $355.00K derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $170.00K 10-Q · filed 2024-08-06 | -$774.00K derived: sum of 3 quarters · filed 2024-08-06 | $943.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $1.20M 10-Q · filed 2024-05-07 | $257.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.97M derived: sum of 3 quarters · filed 2024-05-07 | $2.35M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$944.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $773.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.15M derived: sum of 3 quarters · filed 2024-03-05 | $1.74M 10-K · filed 2024-03-05 |
| 2022-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $2.10M derived: sum of 2 quarters · filed 2023-11-06 | $2.69M 10-Q · filed 2023-11-06 | $3.86M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $379.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $970.00K 10-Q · filed 2023-08-07 | $2.15M derived: sum of 3 quarters · filed 2023-08-07 | $2.17M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $591.00K 10-Q · filed 2023-05-02 | $1.77M derived: sum of 2 quarters · filed 2023-05-02 | $1.79M derived: sum of 3 quarters · filed 2023-05-02 | $1.83M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.20M derived: sum of 2 quarters · filed 2023-03-31 | $1.24M derived: sum of 3 quarters · filed 2023-03-31 | $1.58M 10-K · filed 2023-03-31 |
| 2021-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $64.00K derived: sum of 2 quarters · filed 2022-11-01 | $402.00K 10-Q · filed 2022-11-01 | -$379.00K derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $378.00K 10-Q · filed 2022-08-02 | -$403.00K derived: sum of 3 quarters · filed 2022-08-02 | -$334.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $338.00K 10-Q · filed 2022-05-04 | -$443.00K derived: sum of 2 quarters · filed 2022-05-04 | -$374.00K derived: sum of 3 quarters · filed 2022-05-04 | -$288.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | -$781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$712.00K derived: sum of 2 quarters · filed 2022-03-08 | -$626.00K derived: sum of 3 quarters · filed 2022-03-08 | -$398.00K 10-K · filed 2022-03-08 |
| 2020-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $155.00K derived: sum of 2 quarters · filed 2021-11-02 | $383.00K 10-Q · filed 2021-11-02 | -$882.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $314.00K 10-Q · filed 2021-08-03 | -$951.00K derived: sum of 3 quarters · filed 2021-08-03 | -$1.47M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $228.00K 10-Q · filed 2021-05-04 | -$1.04M derived: sum of 2 quarters · filed 2021-05-04 | -$1.56M derived: sum of 3 quarters · filed 2021-05-04 | -$2.05M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$1.79M derived: sum of 2 quarters · filed 2021-03-09 | -$2.28M derived: sum of 3 quarters · filed 2021-03-09 | -$2.58M 10-K · filed 2021-03-09 |
| 2019-09-30 | -$523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$1.01M derived: sum of 2 quarters · filed 2020-11-04 | -$1.32M 10-Q · filed 2020-11-04 | -$359.00K derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | -$490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$794.00K 10-Q · filed 2020-08-04 | $164.00K derived: sum of 3 quarters · filed 2020-08-04 | $299.00K derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | -$304.00K 10-Q · filed 2020-05-05 | $654.00K derived: sum of 2 quarters · filed 2020-05-05 | $789.00K derived: sum of 3 quarters · filed 2020-05-05 | $1.29M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.09M derived: sum of 2 quarters · filed 2020-03-11 | $1.59M derived: sum of 3 quarters · filed 2020-03-11 | $1.43M 10-K · filed 2020-03-11 |
| 2018-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $634.00K derived: sum of 2 quarters · filed 2019-11-05 | $469.00K 10-Q · filed 2019-11-05 | $117.00K derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | $499.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $334.00K 10-Q · filed 2019-08-06 | -$18.00K derived: sum of 3 quarters · filed 2019-08-06 | -$3.00K derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$165.00K 10-Q · filed 2019-05-08 | -$517.00K derived: sum of 2 quarters · filed 2019-05-08 | -$502.00K derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$337.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.13M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.48M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $1.47M 10-Q · filed 2018-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |